Subscribe to our mailing list

Enter your email:


Enter code above:

When you sign up for our mailing list, you receive our monthly e-newsletter with a summary of news and policy decisions about male contraceptives. We never share your email address.

Prove that there is demand for new male contraceptives




Step 1: Take the Survey

One of the biggest hurdles to the development of new contraceptives for men is the belief that there is no market for such products. Participate in this survey to help dispel that myth. This survey isn’t just for men — the participation of both men and women is important. You can also personalize your interest in new male contraceptives by telling your story.

I am a
Male
Female

I was born in

I live in

My current relationship status is
Single
Married
In a committed relationship
Dating

Do you have any children?

Are you and your partner(s) currently using a method of contraception?
Yes
No

Which methods of contraception have you and your partner(s) used previously? Please check all that apply:

The pill
Male condoms
Female sterilization
 
The patch
Female condoms
Vasectomy
The ring
Sponge
Withdrawal
The shot
Diaphragm
Fertility awareness
The implant
Cervical cap
Lactational amenorrhea
Hormonal IUD
Spermicides
Fertility computers
Copper IUD

If you or your partner(s) stopped using certain methods of contraception, why? Please check all that apply:
Unpleasant side effects
Inconvenience
Not effective enough
Health risks
Too expensive
No longer available / Removed from the market
Wanted to become pregnant
Other... please explain: 

Who has decided which method of contraception you would use? Please check all that have applied in your relationship(s):
I made the decision
My partner made the decision
We made the decision together

 


Where do these survey results go?

The Male Contraception Coalition sends results from this survey and your letters on a quarterly basis to key policymakers and pharmaceutical company decision makers who have the power to speed the development of new male contraceptives. The information collected in this survey is not linked to individuals; read more about this in our privacy policy.